PatSnap, a provider of research and development (R&D) analytics, has launched an online learning hub that will provide users with free courses on intellectual property (IP), PatSnap Academy.
Scientists at the University of Washington (UW) have designed mini-protein binders on a computer platform, which are not naturally occurring and may potentially be possible drug candidates.
The US Food and Drug Administration (FDA) has issued a warning letter to Meridian Medical Technologies, concerning the manufacture of epinephrine auto injectors.
Indivior, a speciality pharmaceutical company, has opened a $30 million research and development (R&D) centre in Hull, UK, to further advance its treatment innovation into the global addiction crisis.
Contract development and manufacturing organisation (CDMO) that specialises in spray drying and capsule filling services, Micro-Sphere, is investing €19 million to expand its GMP manufacturing capabilities at its Swiss facility.
Drug discovery and development company, AiCuris, has been granted fast track designation by the US FDA for oral pritelivir — its lead candidate for the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised adults.
GlaxoSmithKline (GSK) has made several announcements regarding its forthcoming plans to improve the efficiency and competitiveness of its manufacturing network.
Partner to the healthcare and pharma industry, Gerresheimer has announced it will complete its product portfolio of prefillable syringes through an exclusive licence from West Pharmaceutical Services.
Lonza has announced that, following receipt of all required regulatory approvals, it has completed its acquisition of Capsugel for $5.5 billion in cash, including refinancing of existing Capsugel debt of $2 billion.
Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets.
The Sartorius and Science Prize for Regenerative Medicine & Cell Therapy is focused towards scientists advancing research within the relevant fields, with the winner receiving $25,000 in prize money and being published in Science magazine
